SelvitaS.A.Status: Entity active
Research and experimental development on biotechnology
KRS: 0000779822 NIP: 6762564595 REGON: 38304007200000
Overview
Registry date
2019-04-05
Share capital
$3,966,607.02
Activity description
Selvita is an integrated service provider specializing in drug discovery and drug development. It offers comprehensive services from target validation to preclinical candidate nomination, supporting small molecules, antibodies, and protein degraders, along with extensive drug development and regulatory support for both small and large molecules. The company adheres to GMP and GLP regulations, ensuring scientific consistency and global compliance throughout the development process.
Registered address
Ul. Podole 79, 30-394 Kraków, Poland
Website
selvita.comWebsite active
Industry
Authorized Representatives
Ownership
Subsidiaries
| Name | Shares | Share value | % in company | |
|---|---|---|---|---|
| Pozlabsp. z o.o. | 247 | 3,336.03 USD | 100% | |
| Selvita Servicessp. z o.o. | 2,900 | 78,336.03 USD | 100% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| InventionbioS.A. | $16,096,471.81 | inventionbio.pl/ | |
| GenomedS.A. | $5,797,293.91 | genomed.pl | |
| SANO - Centrum Zindywidualizowanej Medycyny Obliczeniowej - Międzynarodowa Fundacja BadawczaFoundation | $4,616,991.23 | sano.science/ | |
| Read-GeneS.A. | $3,389,688.05 | read-gene.com | |
| BiotechnaS.A. | $2,465,682.54 | bsbiotechna.com | |
| MedappS.A. | $1,899,273.37 | medapp.pl | |
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.06 | eitrawmaterials.eu | |
| RDLSsp. z o.o. | $1,680,515.41 | rdls.pl | |
| FamicordtxS.A. | $1,365,068.40 | famicordtx.com | |
| SDS OpticS.A. | $1,358,706.84 | sdsoptic.pl |
Last updated: 2026-03-21